The article focuses on the baseline characteristics, including blood and urine metal levels, in participants of the Trial to Assess Chelation Therapy 2 (TACT2). The study investigates the impact of heavy metal exposure on cardiovascular health and explores the potential of chelation therapy to reduce cardiovascular risks. The research highlights
